Washington, D.C. 20549

                                    FORM 8-K

                                CURRENT REPORT
                      PURSUANT TO SECTION 13 OR 15(d) OF
                     THE SECURITIES EXCHANGE ACT OF 1934

        Date of Report (date of earliest event reported): March 21, 2011

                                Aehr Test Systems
             (Exact name of Registrant as specified in its charter)

          California                    000-22893             94-2424084
(State or other jurisdiction of  (Commission File Number)  (I.R.S. Employer
 incorporation or organization)                         Identification Number)

                               400 Kato Terrace
                           Fremont, California 94539
         (Address of principal executive offices, including zip code)

             (Registrant's telephone number, including area code)

         (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))

ITEM 3.01.  Notice of Delisting or Failure to Satisfy a Continued Listing Rule
or Standard; Transfer of Listing

	On March 21, 2011, Aehr Test Systems (the "Company") submitted an
application to the NASDAQ Stock Market ("Nasdaq") to transfer the listing of
its Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market.
This action responds to the previously reported letter received by the Company
from Nasdaq on January 18, 2011 stating that the Company no longer met the
minimum stockholders' equity requirement for the Company to remain on the
Nasdaq Global Market.

On March 24, 2011, the Company received a letter from Nasdaq informing
it that the Nasdaq Listing Qualifications Staff had granted the Company's
request to transfer the listing of its common stock to The Nasdaq Capital
Market, effective at the opening of business on March 28, 2011.  The Company's
common stock will continue to trade under the symbol "AEHR."


            Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                               Aehr Test Systems
Date:  March 25, 2011
                                          By:   /S/ GARY L. LARSON
                                               Gary L. Larson
                                               Vice President of Finance and
                                               Chief Financial Officer